NCI, Inc. (NCIT) Given a $24.00 Price Target at Cowen and Company

Cowen and Company set a $24.00 price target on NCI, Inc. (NASDAQ:NCIT) in a research report released on Thursday. The firm currently has a buy rating on the information technology services provider’s stock.

Several other equities research analysts also recently weighed in on NCIT. Zacks Investment Research downgraded shares of NCI from a buy rating to a hold rating in a research report on Tuesday, August 15th. Noble Financial reissued a buy rating on shares of NCI in a research report on Wednesday, June 14th. SunTrust Banks, Inc. downgraded shares of NCI from a buy rating to a hold rating and dropped their target price for the stock from $24.00 to $20.00 in a research report on Monday, July 3rd. Finally, ValuEngine raised shares of NCI from a hold rating to a buy rating in a research report on Friday, June 2nd. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. The company currently has an average rating of Hold and an average target price of $18.33.

NCI (NCIT) opened at 20.00 on Thursday. The stock has a market capitalization of $272.32 million, a P/E ratio of 46.51 and a beta of 1.01. The firm’s 50-day moving average price is $20.07 and its 200 day moving average price is $16.90. NCI has a 12-month low of $10.98 and a 12-month high of $21.40.

ILLEGAL ACTIVITY WARNING: “NCI, Inc. (NCIT) Given a $24.00 Price Target at Cowen and Company” was first reported by Transcript Daily and is owned by of Transcript Daily. If you are reading this news story on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this news story can be viewed at https://transcriptdaily.com/2017/08/21/nci-inc-ncit-given-a-24-00-price-target-at-cowen-and-company.html.

Several large investors have recently made changes to their positions in the stock. Royce & Associates LP acquired a new stake in shares of NCI during the first quarter worth $7,663,000. FMR LLC increased its stake in shares of NCI by 21.2% in the second quarter. FMR LLC now owns 928,957 shares of the information technology services provider’s stock worth $19,601,000 after buying an additional 162,257 shares in the last quarter. Kennedy Capital Management Inc. acquired a new stake in shares of NCI during the second quarter worth $1,735,000. OxFORD Asset Management LLP acquired a new stake in shares of NCI during the second quarter worth $1,425,000. Finally, Algert Global LLC increased its stake in shares of NCI by 527.3% in the second quarter. Algert Global LLC now owns 76,251 shares of the information technology services provider’s stock worth $1,609,000 after buying an additional 64,096 shares in the last quarter. 38.58% of the stock is owned by institutional investors and hedge funds.

About NCI

NCI, Inc is a provider of enterprise services and solutions to defense, intelligence, healthcare and civilian government agencies. The Company provides information technology (IT), and professional services and solutions by leveraging its core service offerings, which include cloud computing and IT infrastructure optimization; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; health IT and medical support; IT service management; modeling, simulation, and training, and agile development and integration.

Receive News & Ratings for NCI Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NCI Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply